This is a Validated Antibody Database (VAD) review about human CYP2D6, based on 2 published articles (read how Labome selects the articles), using CYP2D6 antibody in all methods. It is aimed to help Labome visitors find the most suited CYP2D6 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CYP2D6 synonym: CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1; cytochrome P450 2D6; cholesterol 25-hydroxylase; cytochrome P450, family 2, subfamily D, polypeptide 6; cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2; cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2; cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing)-like 1; cytochrome P450-DB1; debrisoquine 4-hydroxylase; flavoprotein-linked monooxygenase; microsomal monooxygenase; nonfunctional cytochrome P450 2D6; xenobiotic monooxygenase
Sigma-Aldrich
rabbit polyclonal |
| Sigma-Aldrich CYP2D6 antibody (Sigma Aldrich, AV41675) was used in immunocytochemistry on human samples at 1:200 (fig 6e). Stem Cell Res (2016) ncbi |
rabbit polyclonal |
| In order to report the generation of human fibroblast-derived hepatocytes that can be used to repopulate mouse livers, Sigma-Aldrich CYP2D6 antibody (Sigma, AV41675) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig s9). Nature (2014) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments